Meet our Researchers: Dr Mark Murakami and Dr Reid Merryman

Dr Mark Murakami and Dr Reid Merryman share more about their work to understand one of the most promising areas in follicular lymphoma treatment – bispecific antibodies. As part of the Research United to CURE FL awards programme - co funded by the Follicular Lymphoma Foundation, Blood Cancer United and the Institute for Follicular Lymphoma Innovation - their research focuses on how people living with FL respond to these therapies when treated earlier. This includes who benefits most, how long treatment should be given, and how to maximise benefit while minimising side effects. By studying patient responses in more detail, this work is helping guide how these treatments can be used more effectively – with the aim of achieving deeper, longer lasting responses and ultimately moving closer to cure. ------------------------------------------------------------------------------------------------------------- The Research United to CURE FL Awards program was launched in 2024, read more about our program grantees here: https://www.theflf.org/our-research/o... If you're unsure about any of the terms and treatments discussed, please visit our glossary: https://www.theflf.org/your-support-h... If you've found our videos helpful, please consider donating to the Follicular Lymphoma Foundation. Your support helps us accelerate research towards a cure for FL and improve the lives of those affected: https://www.theflf.org/donate/ [Disclaimer: This video is intended for educational and awareness purposes only and the information presented and discussed does not constitute medical advice. The video may contain data and information regarding not yet approved treatments and/or off-label use which are not to be construed as recommendations. Please consult with your healthcare provider for medical advice.]